Spring Bank Pharmaceuticals, Inc. (SBPH)
(Delayed Data from NSDQ)
$7.05 USD
+0.16 (2.32%)
Updated May 3, 2019 04:00 PM ET
After-Market: $6.94 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.05 USD
+0.16 (2.32%)
Updated May 3, 2019 04:00 PM ET
After-Market: $6.94 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
5 Must-Buy Small Caps for Big Returns in 2020
by Zacks Equity Research
The upbeat sentiments prevailing in Wall Street make investment in small caps stocks attractive for 2020, here's why.
Company News For Dec 27, 2019
by Zacks Equity Research
Companies In The News Are: QGEN, IMMU, CANF, SBPH
Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down
by Zacks Equity Research
Spring Bank (SBPH) declines as it stops dosing and enrolling patients in phase IIb studies on inarigivir.
Top Ranked Momentum Stocks to Buy for December 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 24th
Will Spring Bank Pharmaceuticals Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Spring Bank Pharmaceuticals.
Top Ranked Momentum Stocks to Buy for December 11th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 11th
Spring Bank Pharmaceuticals, Inc. (SBPH) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Spring Bank Pharmaceuticals, Inc. (SBPH).
Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales
by Zacks Equity Research
Arena Pharmaceuticals (ARNA) betters loss estimates in Q3. Also, the top line surpasses the consensus mark.